UC Davis Venture Catalyst will be hosting an SBIR/STTR Knowledge Exchange event on Tuesday, July 24, 2018. This talk will offer a unique opportunity for participants to learn about Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications from the perspective of a reviewer.
The SBIR/STTR program provides non-dilutive funding to small advanced technology firms to spur new technological discoveries and facilitate the commercialization of innovations. Of course, the program is extremely competitive. As a recurring NIH panel participant and Study Section Chair, David Spellmeyer has inside intel about how SBIR/STTR applications are evaluated. He will discuss what a winning application looks like, the essential elements to include and how to get the reviewers’ attention. He will also inform participants about the intricacies of the grant review process.
When:
Tuesday, July 24, 2018, 5:30PM – 8PM
Where:
UC Davis Office of Research
1850 Research Park Drive
Davis, CA 95618
About the Speaker
Dr. Spellmeyer is a biotechnology executive with 25 years of broad experience in the life sciences industry. He regularly participates in NIH SBIR/STTR Study Sections as both a panel reviewer and as Chair. He currently serves as CSO at Circle Pharma, as an Executive-in-Residence at ShangPharma Innovation, and heads Interlaken Associates where he advises early-stage companies and investors on corporate and technical strategy, product development, and commercialization. He previously served in research leadership roles at both large and small companies. Dr. Spellmeyer received his BS in computer science and chemistry from Purdue University and his PhD in theoretical organic chemistry from UCLA. He completed postdoctoral training in pharmaceutical chemistry at UCSF, where he is an adjunct Associate Professor.
